Verified· 2 sources

AKROSWISS AG

Summary

About the company

The core activity of Akroswiss is the development and marketing of innovative nasal treatments for central nervous system (CNS) diseases, particularly for epileptic seizures and anxiety disorders (claustrophobia) during MRI examinations. The company focuses on developing minimally invasive, intranasal drug formulations with a unique 360° function for rapid and effective administration.

AI-generated

Offering

Products & services

Industry:Pharmaceutical Industry

Outbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub

AKROSWISS AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

AKROSWISS AG

About the company

Products & services

Looking for direct email addresses and phone numbers?

No knowledge articles yet

AKROSWISS AG in comparison

Industry comparisons are coming soon

Similar companies